表紙
市場調查報告書
商品編碼
1045367

微生物產品的全球市場(2022年∼2026年)

Global Microbial Products Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球微生物產品的市場規模在2022年∼2026年的預測期間內,預計將以12.20%的年複合成長率推移,並成長到184億1,000萬美元。

市場成長的主要因素有製藥產業對微生物產品的高需求,及微生物的發現·治療·診斷的進步等。

本報告提供全球微生物產品市場調查,提供市場概要,市場規模和預測,趨勢,成長要素及課題,客戶形勢,應用·各地區的分析,再加上業者情勢及供應商分析等資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:從2021年∼2026年的預測

波特的五力分析

  • 五力摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

各應用領域市場區隔

  • 市場區隔
  • 各應用領域比較
  • 醫藥品:市場規模與預測(2021年∼2026年)
  • 診斷:市場規模與預測(2021年∼2026年)
  • 生物科技:市場規模與預測(2021年∼2026年)
  • 各應用領域的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2021年∼2026年)
  • 歐洲:市場規模與預測(2021年∼2026年)
  • 亞洲:市場規模與預測(2021年∼2026年)
  • 其他地區:市場規模與預測(2021年∼2026年)
  • 主要國家
  • 各地區形勢的市場機會
  • 推動市場要素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • bioMerieux SA
  • GlaxoSmithKline Plc
  • Kyowa Hakko Bio Co. Ltd.
  • Merck KGaA
  • NovaMedica
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Thermo Fisher Scientific Inc.
  • Valent BioSciences LLC

附錄

目錄
Product Code: IRTNTR71908

Technavio has been monitoring the microbial products market and it is poised to grow by $ 18.41 bn during 2022-2026, progressing at a CAGR of 12.20% during the forecast period. Our report on the microbial products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for microbial products in the pharmaceutical industry and advances in discovery, therapeutics, and diagnostics of microbes. In addition, High demand for microbial products in the pharmaceutical industry is anticipated to boost the growth of the market as well.

The microbial products market analysis includes the application segment and geographic landscape.

Technavio's microbial products market is segmented as below:

By Application

  • Pharmaceutical
  • Diagnostics
  • Biotechnology

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the changes in the lifestyles of human beings and the environmentas one of the prime reasons driving the microbial products market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on microbial products market covers the following areas:

  • Microbial products market sizing
  • Microbial products market forecast
  • Microbial products market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microbial products market vendors that include bioMerieux SA, GlaxoSmithKline Plc, Kyowa Hakko Bio Co. Ltd., Merck KGaA, NovaMedica, Novartis AG, Pfizer Inc., Sanofi SA, Thermo Fisher Scientific Inc., and Valent BioSciences LLC. Also, the microbial products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Application
    • Market segments
    • Comparison by Application
    • Pharmaceutical - Market size and forecast 2021-2026
    • Diagnostics - Market size and forecast 2021-2026
    • Biotechnology - Market size and forecast 2021-2026
    • Market opportunity by Application
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2021-2026
    • Europe - Market size and forecast 2021-2026
    • Asia - Market size and forecast 2021-2026
    • ROW - Market size and forecast 2021-2026
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • bioMerieux SA
    • GlaxoSmithKline Plc
    • Kyowa Hakko Bio Co. Ltd.
    • Merck KGaA
    • NovaMedica
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • Valent BioSciences LLC
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2021 - 2026 ($ million)
  • 13: Global market: Year-over-year growth 2021 - 2026 (%)
  • 14: Five forces analysis 2021 & 2026
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2021
  • 21: Application - Market share 2021-2026 (%)
  • 22: Comparison by Application
  • 23: Pharmaceutical - Market size and forecast 2021-2026 ($ million)
  • 24: Pharmaceutical - Year-over-year growth 2021-2026 (%)
  • 25: Diagnostics - Market size and forecast 2021-2026 ($ million)
  • 26: Diagnostics - Year-over-year growth 2021-2026 (%)
  • 27: Biotechnology - Market size and forecast 2021-2026 ($ million)
  • 28: Biotechnology - Year-over-year growth 2021-2026 (%)
  • 29: Market opportunity by Application
  • 30: Customer landscape
  • 31: Market share By Geographical Landscape 2021-2026 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2021-2026 ($ million)
  • 34: North America - Year-over-year growth 2021-2026 (%)
  • 35: Europe - Market size and forecast 2021-2026 ($ million)
  • 36: Europe - Year-over-year growth 2021-2026 (%)
  • 37: Asia - Market size and forecast 2021-2026 ($ million)
  • 38: Asia - Year-over-year growth 2021-2026 (%)
  • 39: ROW - Market size and forecast 2021-2026 ($ million)
  • 40: ROW - Year-over-year growth 2021-2026 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: bioMerieux SA - Overview
  • 50: bioMerieux SA - Business segments
  • 51: bioMerieux SA - Key offerings
  • 52: bioMerieux SA - Key customers
  • 53: bioMerieux SA - Segment focus
  • 54: GlaxoSmithKline Plc - Overview
  • 55: GlaxoSmithKline Plc - Business segments
  • 56: GlaxoSmithKline Plc - Key offerings
  • 57: GlaxoSmithKline Plc - Key customers
  • 58: GlaxoSmithKline Plc - Segment focus
  • 59: Kyowa Hakko Bio Co. Ltd. - Overview
  • 60: Kyowa Hakko Bio Co. Ltd. - Product and service
  • 61: Kyowa Hakko Bio Co. Ltd. - Key offerings
  • 62: Kyowa Hakko Bio Co. Ltd. - Key customers
  • 63: Kyowa Hakko Bio Co. Ltd. - Segment focus
  • 64: Merck KGaA - Overview
  • 65: Merck KGaA - Product and service
  • 66: Merck KGaA - Key offerings
  • 67: Merck KGaA - Key customers
  • 68: Merck KGaA - Segment focus
  • 69: NovaMedica - Overview
  • 70: NovaMedica - Product and service
  • 71: NovaMedica - Key offerings
  • 72: NovaMedica - Key customers
  • 73: NovaMedica - Segment focus
  • 74: Novartis AG - Overview
  • 75: Novartis AG - Business segments
  • 76: Novartis AG - Key offerings
  • 77: Novartis AG - Key customers
  • 78: Novartis AG - Segment focus
  • 79: Pfizer Inc. - Overview
  • 80: Pfizer Inc. - Business segments
  • 81: Pfizer Inc. - Key offerings
  • 82: Pfizer Inc. - Key customers
  • 83: Pfizer Inc. - Segment focus
  • 84: Sanofi SA - Overview
  • 85: Sanofi SA - Business segments
  • 86: Sanofi SA - Key offerings
  • 87: Sanofi SA - Key customers
  • 88: Sanofi SA - Segment focus
  • 89: Thermo Fisher Scientific Inc. - Overview
  • 90: Thermo Fisher Scientific Inc. - Business segments
  • 91: Thermo Fisher Scientific Inc. - Key offerings
  • 92: Thermo Fisher Scientific Inc. - Key customers
  • 93: Thermo Fisher Scientific Inc. - Segment focus
  • 94: Valent BioSciences LLC - Overview
  • 95: Valent BioSciences LLC - Product and service
  • 96: Valent BioSciences LLC - Key offerings
  • 97: Valent BioSciences LLC - Key customers
  • 98: Valent BioSciences LLC - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations